Hemab Therapeutics Holdings, Inc. · NASDAQ:COAG
FMR LLC reported a 7.90% stake in Hemab Therapeutics Holdings, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 6, 2026
FMR LLC reported a 7.90% stake in Hemab Therapeutics Holdings, Inc., 3,697,837 shares, as a passive investor on Jun 30, 2026. Filed Aug 6, 2026 (Schedule 13G).
- Stake
- 7.90%
- Shares
- 3,697,837
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 7.90% | 3,697,837 |
| Abigail P. Johnson | 7.90% | 3,697,837 |
Source
Related
- Hemab Therapeutics Holdings, Inc.
- FMR LLC
- Hemab Therapeutics Holdings, Inc. shareholders
- Schedule 13G · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G · Novo Holdings A/S · Aug 14, 2026
- Schedule 13G · Capital International Investors · Aug 12, 2026
- Schedule 13G · Invus Public Equities, L.P. · Aug 7, 2026
- Schedule 13G · Sofinnova Crossover II SLP · Aug 5, 2026